Leonetti & Associates’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Leonetti & Associates’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-142,441	Closed	-$13.7M	–	39
2018 Q3	$13.7M	Buy	142,441 +3,216	+2%	+$312K	3.49%	8
2018 Q2	$13.3M	Buy	139,225 +40,150	+41%	+$3.69M	3.6%	7
2018 Q1	$8.69M	Buy	+99,075	New	+$9.04M	2.52%	10
2017 Q2	–	Sell	-152,050	Closed	-$10.5M	–	44
2017 Q1	$10.5M	Buy	152,050 +725	+0.5%	+$48.7K	3.06%	8
2016 Q4	$8.96M	Sell	151,325 -3,925	-3%	-$242K	2.64%	14
2016 Q3	$10.3M	Buy	+155,250	New	+$9.6M	2.91%	13

Other funds holding XBI

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

BCWM LLC Overland Park, Kansas $353M AUM 20.1% 1-Year Est. Return

Leonetti & Associates's XBI Position: Q4 2018 in Review

Leonetti & Associates sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2018, closing a stake of 142,441 shares — an estimated $13.7M sold.

Leonetti & Associates first reported a position in XBI in Q3 2016 and held it in 6 quarters. The position peaked at $13.7M in Q3 2018. 427 funds tracked by Wall St. Rank hold XBI as of Q4 2018.

Leonetti & Associates reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2018 after selling out during the quarter.
Leonetti & Associates sold 142,441 State Street SPDR S&P Biotech ETF shares in Q4 2018, an estimated $13.7M.
Leonetti & Associates first reported a position in State Street SPDR S&P Biotech ETF in Q3 2016 and held it in 6 quarters.
Leonetti & Associates's State Street SPDR S&P Biotech ETF position peaked at $13.7M in Q3 2018.
427 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2018.

Based on Leonetti & Associates's 13F filing for Q4 2018, filed 19 Feb 2019.